» Articles » PMID: 26609244

Management of Knee Osteoarthritis by Combined Stromal Vascular Fraction Cell Therapy, Platelet-rich Plasma, and Musculoskeletal Exercises: a Case Series

Overview
Journal J Pain Res
Publisher Dove Medical Press
Date 2015 Nov 27
PMID 26609244
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Knee osteoarthritis is associated with persistent joint pain, stiffness, joint deformities, ligament damage, and surrounding muscle atrophy. The complexity of the disease makes treatment difficult. There are no therapeutic drugs available to halt the disease progression, leaving patients dependent on pain medication, anti-inflammatory drugs, or invasive joint replacement surgery.

Case Presentations: Four patients with a history of unresolved symptomatic knee osteoarthritis were investigated for the therapeutic outcome of combining an exercise rehabilitation program with intra-articular injections of autologous StroMed (ie, stromal vascular fraction cells concentrated by ultrasonic cavitation from lipoaspirate) and platelet-rich plasma (PRP). The Knee Injury and Osteoarthritis Outcome Score questionnaire (KOOS) was administered along with physical function tests over a 12-month period. The first patient achieved a maximum therapeutic outcome of 100 in all five KOOS subscales (left knee), and 100 for four subscales (right knee). The second patient scored 100 in all five KOOS subscales (left knee), and greater than 84 in all subscales (right knee). Treatment of the third patient resulted in improved outcomes in both knees of >93 for four KOOS subscales, and 60 for the Function in Sport and Recreation subscale. The fourth patient improved to 100 in all five KOOS subscales. In all patients, the physical function "Get-up and Go" test and "Stair Climbing Test" returned to normal (a value of zero).

Conclusion: This case series indicates that improved outcomes may be obtained when autologous stromal vascular fraction (StroMed) cell therapy is combined with traditional exercise practices and PRP for osteoarthritis. Of the seven joints treated: all patients' scores of pain improved to >96; and quality of life scores to >93. Functional performance measures of mobility returned to normal. This simple treatment appears to be extremely effective for osteoarthritis disorders that have no drug treatment to halt disease progression.

Citing Articles

Adipose tissue-derived injectable products combined with platelet-rich plasma for the treatment of osteoarthritis: the promising preclinical results are not confirmed by the clinical evidence.

Orazi S, Boffa A, Salerno M, Angelelli L, Zaffagnini S, Filardo G EFORT Open Rev. 2024; 9(11):1023-1033.

PMID: 39513707 PMC: 11619720. DOI: 10.1530/EOR-24-0050.


Current Non-Surgical Curative Regenerative Therapies for Knee Osteoarthritis.

Bahari Golamkaboudi A, Vojoudi E, Roshani K, Porouhan P, Houshangi D, Barabadi Z Stem Cell Rev Rep. 2024; 20(8):2104-2123.

PMID: 39145857 DOI: 10.1007/s12015-024-10768-6.


Effects of platelet-rich plasma combined with isometric quadriceps contraction on cartilage in a rat model of knee osteoarthritis.

Cheng L, Wang K, Chang S, Tan Y, He B Regen Ther. 2024; 26:469-477.

PMID: 39070125 PMC: 11283084. DOI: 10.1016/j.reth.2024.06.021.


Clinical Outcome of Minimally Manipulated, Mechanically Isolated Autologous Adipose Tissue-Derived Stromal Vascular Fraction (Sahaj Therapy®) in Knee Osteoarthritis-Randomized Controlled Trial.

Tantuway V, Thomas W, Parikh M, Sharma R, Jeyaraman N, Jeyaraman M Indian J Orthop. 2023; 57(10):1646-1658.

PMID: 37766954 PMC: 10519910. DOI: 10.1007/s43465-023-00981-9.


Circulating Endothelial Progenitor and Mesenchymal Stromal Cells as Biomarkers for Monitoring Disease Status and Responses to Exercise.

Gollie J, Sen S Rev Cardiovasc Med. 2023; 23(12):396.

PMID: 37680455 PMC: 10483375. DOI: 10.31083/j.rcm2312396.


References
1.
Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

2.
Pak J . Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. J Med Case Rep. 2011; 5:296. PMC: 3154169. DOI: 10.1186/1752-1947-5-296. View

3.
Patel S, Dhillon M, Aggarwal S, Marwaha N, Jain A . Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013; 41(2):356-64. DOI: 10.1177/0363546512471299. View

4.
Roos E, Lohmander L . The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003; 1:64. PMC: 280702. DOI: 10.1186/1477-7525-1-64. View

5.
Felson D, Lawrence R, Dieppe P, Hirsch R, Helmick C, Jordan J . Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000; 133(8):635-46. DOI: 10.7326/0003-4819-133-8-200010170-00016. View